Merck & Co. Inc. buy Guggenheim
Start price
11.04.23
/
50%
€103.40
Target price
11.04.24
€113.61
Performance (%)
13.73%
End price
12.04.24
€117.60
Summary
This prediction ended on 12.04.24 with a price of €117.60. The BUY prediction by Guggenheim finished with a performance of 13.73%. Guggenheim has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €2.77 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | -0.314% | -0.314% | 2.922% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Guggenheim from $123.00 to $124.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.40
12.02.25
12.02.25
€110.77
12.02.26
12.02.26
15.00%
21.01.26
21.01.26
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€68.70
17.04.25
17.04.25
€101.20
17.04.26
17.04.26
38.43%
21.01.26
21.01.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-21.04%
07.11.25
07.11.25